Efficacy and Safety of Izokibep, a Novel IL 17A Inhibitor, in Moderate[...]
09/27/2024 | Press release | Distributed by Public on 09/27/2024 04:35
Please select the service you want to use:
Smartlinks | PRIO SA | Finance | Security Markets | Security Markets | Company News | Investment Funds | Professional and Business Services | Legal Services | Securities Issuers | Oil and Gas Exploration and Production Companies | Sao Paulo Stock Exchange (B3) | Buenos Aires Stock Exchange (BCBA) | OTC Markets
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact